|
05/09/2025 08:00 AM EDT
A Pennsylvania man was sentenced today in the District of New Jersey to four years and nine months in prison for conspiracy to distribute oxycodone, a highly addictive controlled substance.
05/09/2025 08:00 AM EDT
The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) drug Lazanda for individuals who did not have breakthrough cancer pain.
No comments:
Post a Comment